0001225208-22-006073.txt : 20220425
0001225208-22-006073.hdr.sgml : 20220425
20220425163328
ACCESSION NUMBER: 0001225208-22-006073
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220421
FILED AS OF DATE: 20220425
DATE AS OF CHANGE: 20220425
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hait William
CENTRAL INDEX KEY: 0001904791
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03215
FILM NUMBER: 22850106
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLAZA
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: JOHNSON & JOHNSON
CENTRAL INDEX KEY: 0000200406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221024240
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 0101
BUSINESS ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
BUSINESS PHONE: 732-524-2455
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
4
1
doc4.xml
X0306
4
2022-04-21
0000200406
JOHNSON & JOHNSON
JNJ
0001904791
Hait William
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK
NJ
08933
1
See Remarks
Common Stock
2022-04-21
4
M
0
29699.0000
90.4400
A
109935.0000
D
Common Stock
2022-04-21
4
S
0
100.0000
183.5770
D
109835.0000
D
Common Stock
2022-04-21
4
S
0
100.0000
183.5770
D
109735.0000
D
Common Stock
2022-04-21
4
S
0
225.0000
183.5770
D
109510.0000
D
Common Stock
2022-04-21
4
S
0
700.0000
183.5770
D
108810.0000
D
Common Stock
2022-04-21
4
S
0
1403.0000
183.5770
D
107407.0000
D
Common Stock
2022-04-21
4
S
0
1696.0000
183.5770
D
105711.0000
D
Common Stock
2022-04-21
4
S
0
2884.0000
183.5770
D
102827.0000
D
Common Stock
2022-04-21
4
S
0
22591.0000
183.5770
D
80236.0000
D
Employee Stock Options (Right to Buy)
90.4400
2022-04-21
4
M
0
29699.0000
0.0000
D
2017-02-11
2024-02-09
Common Stock
29699.0000
29698.0000
D
This transaction was executed in multiple trades at prices ranging from 183.57 to 183.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Title: Executive Vice President, Chief External Innovation, Medical Safety and Global Public Health Officer
Raavi Deol, as attorney-in-fact for William Hait
2022-04-25